185P Interim analysis of the EOGBM1-18 study: Strong immune response to therapeutic vaccination with EO2401 microbiome derived therapeutic vaccine + nivolumab

Wick, W. ; Gamelas Magalhaes, J. ; Dos Santos Leite, A.M. ; IdBaih, A. ; Vieito Villar, M. ; Tabatabai, G. ; Stradella, A. ; Ghiringhelli, F. ; Burger, M. ; Mildenberger, I. ; Herrlinger, U. ; Touat, M. ; Wen, P. ; Wick, A. ; Toussaint, H. ; Gouttefangeas, C. ; Bonny, C. ; Paillarse, J-M. ; Reardon, D.A.

Immuno-oncology technology, 2022-12, Vol.16, p.100297, Article 100297 [Periódico revisado por pares]

Texto completo disponível